Cannabis-Induced Depersonalization Disorder in Adolescence

@article{Hrlimann2012CannabisInducedDD,
  title={Cannabis-Induced Depersonalization Disorder in Adolescence},
  author={F. H{\"u}rlimann and Stephan Kupferschmid and Andor E. Simon},
  journal={Neuropsychobiology},
  year={2012},
  volume={65},
  pages={141 - 146}
}
We present a case series of 6 patients who developed persistent depersonalization disorder in adolescence after consuming cannabis. In 2 of these cases, the illness course was severely disabling. Within the growing body of literature that investigates the effects of cannabis use on mental health, the association between cannabis and depersonalization disorder is widely neglected. We review the clinical characteristics of this disorder and summarize the neurobiological evidence relating it to… 
View on PubMed
doi.org
16 Citations
Background Citations
4

16 Citations

Cannabis Induced Psychopathology
TLDR
Clinicians are told that there are treatments that may help patients achieve abstinence, and even neuroprotective strategies to employ in cases of new-onset cannabisinduced psychosis, as well as for cases of in utero exposure.
Anomalous Self-Experiences: Markers of Schizophrenia Vulnerability or Symptoms of Depersonalization Disorder? A Phenomenological Investigation of Two Cases
TLDR
The DPD case may be characterized only by secondary ASEs and thus better protected against psychotic decompensation than the SPD case, tentatively affected by a combination of primary and secondary A SEs.
Commentary about social avoidance and its significance in adolescents and young adults
Prevalence and correlates of depersonalization in students aged 12–18 years in Germany
TLDR
Experiences of depersonalization were very common among adolescents and may indicate an increased risk for poor academic achievement and mental health in the long term.
Cenesthopathy in adolescence: an appraisal of diagnostic overlaps along the anxiety-hypochondriasis-psychosis spectrum.
Marijuana: Current Concepts†
TLDR
Current research on use of Cannabis sativa and its constituents such as the cannabinoids is considered and the potential role of specific cannabinoids for medical benefit will be revealed as the twenty-first century matures.
Phenomenal depth: A common phenomenological dimension in depression and depersonalization
Describing, understanding, and explaining subjective experience in depression is a great challenge for psychopathology. Attempts to uncover neurobiological mechanisms of those experiences are in need…
Cannabis and Drug-Facilitated Crimes
Moving beyond transition outcomes: Meta-analysis of remission rates in individuals at high clinical risk for psychosis
Allergenicity to Cannabis sativa L. and Methods to Assess Personal Exposure
TLDR
This chapter will examine the scenarios and routes of exposure to C. sativa that may result in allergic sensitization and provide insights into the key allergic determinants and the methodological challenges associated with studying the plant and the biotechnological advances in exposure assessment.
...
...

References

SHOWING 1-10 OF 46 REFERENCES
Feeling unreal: a depersonalization disorder update of 117 cases.
TLDR
The characteristics of depersonalization disorder found in this sample, the largest described to date, are in good accord with previous literature, and the study highlights the need for novel therapeutic approaches to treat depersonALization disorder.
Depersonalisation disorder: clinical features of 204 cases
TLDR
Depersonalisation disorder is a recognisable clinical entity but appears to have significant comorbidity with anxiety and depression and research into its aetiology and treatment is warranted.
Is depersonalization disorder initiated by illicit drug use any different? A survey of 394 adults.
TLDR
The study strongly supports a uniform syndrome for chronic depersonalization/derealization regardless of precipitant and shows significantly greater improvement over time than the ND group.
Cannabis use and the risk of later schizophrenia: a review.
TLDR
Antecedent cannabis use appears to act as a risk factor in the onset of schizophrenia, especially in vulnerable people, but also in people without prior history.
Chronic depersonalization following illicit drug use: a controlled analysis of 40 cases.
TLDR
Drug-induced DP does not appear to represent a distinct clinical syndrome, and the neurocognitive mechanisms of the genesis and maintenance of DP are likely to be similar across clinical groups, regardless of precipitants.
De-constructing depersonalization: Further evidence for symptom clusters
Dissociative disorders among adults in the community, impaired functioning, and axis I and II comorbidity.
Prevalence, Correlates, and Predictors of Depersonalization Experiences in the German General Population
TLDR
It is concluded that DP is common, it can not be reduced to a negligible variant of depression or anxiety and that more awareness about DP with respect to detection and research is urgently required.
Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia
Causal association between cannabis and psychosis: examination of the evidence
TLDR
Cases of psychotic disorder could be prevented by discouraging cannabis use among vulnerable youths and research is needed to understand the mechanisms by which cannabis causes psychosis.
...
...